Egerton Capital
United Kingdom · Fundamental, long-term global equities
London investment manager founded by John Armitage. Holdings shown belong to the filing entity, not to any individual.
Following and alerts are member features.
- Reporting period
- Q3 2026 (ended 30 Sep 2026)
- Filed on
- 20 Oct 2026
- Processed on
- 16 Nov 2026
Reporting entity tracked: Egerton Capital (UK) LLP · Official website: not recorded · Source document: Q3 2026 filing. See source records.
Key metrics
Disclosed holdings
23
Q3 2026
New positions
4
vs previous disclosure
Increased
9
vs previous disclosure
Reduced
10
vs previous disclosure
Exited (confirmed)
0
+4 no longer reported, unconfirmed
Reported value
$9.82bn
At 30 Sep 2026
Top disclosed holdings
Share of disclosed value · Q3 2026
- Visa Inc.14.9%
- Amazon.com, Inc.12.0%
- Amphenol Corp.9.2%
- Nvidia Corp.8.7%
- Moody's Corp.7.6%
Concentration: top five holdings are 52.4% of disclosed value.
Sector allocation
Share of disclosed value · Q3 2026
- Financials32.6%
- Information Technology19.3%
- Consumer Discretionary13.0%
- Communication Services8.7%
- Materials7.5%
- Energy5.1%
- Industrials4.9%
- Health Care4.7%
- Unclassified1.6%
- Utilities1.3%
- Real Estate1.3%
Geographic exposure
By company domicile · Q3 2026
- United States92.5%
- Ireland3.1%
- Brazil2.5%
- United Kingdom1.9%
Disclosed holdings
Search, sort and filter holdings, or switch to an earlier disclosure to view historical holdings.
- Reduced
- Shares
- 4.08m
- Value
- $1.47bn
- Weight
- 14.9%
- Amazon.com, Inc.Increased
AMZN
- Shares
- 4.71m
- Value
- $1.17bn
- Weight
- 12.0%
- Increased
- Shares
- 10.71m
- Value
- $902.7m
- Weight
- 9.2%
- Nvidia Corp.Increased
NVDA
- Shares
- 3.74m
- Value
- $854.6m
- Weight
- 8.7%
- Reduced
- Shares
- 1.64m
- Value
- $743.5m
- Weight
- 7.6%
- Reduced
- Shares
- 2.1m
- Value
- $715.3m
- Weight
- 7.3%
- Increased
- Shares
- 10.83m
- Value
- $498.6m
- Weight
- 5.1%
- Medline Inc.Reduced
MDLN
- Shares
- 13.28m
- Value
- $460.9m
- Weight
- 4.7%
- S&P Global Inc.Increased
SPGI
- Shares
- 790k
- Value
- $311.8m
- Weight
- 3.2%
- Reduced
- Shares
- 3.63m
- Value
- $300.7m
- Weight
- 3.1%
- Reduced
- Shares
- 3.16m
- Value
- $270.0m
- Weight
- 2.7%
- Reduced
- Shares
- 1.01m
- Value
- $246.6m
- Weight
- 2.5%
- Embraer S.a.Reduced
EMBJ
- Shares
- 3.24m
- Value
- $244.2m
- Weight
- 2.5%
- Increased
- Shares
- 1.06m
- Value
- $236.0m
- Weight
- 2.4%
- New position
- Shares
- 1.47m
- Value
- $223.1m
- Weight
- 2.3%
- Reduced
- Shares
- 348k
- Value
- $191.7m
- Weight
- 2.0%
- Linde plcIncreased
LIN
- Shares
- 402k
- Value
- $190.8m
- Weight
- 1.9%
- Increased
- Shares
- 993k
- Value
- $160.9m
- Weight
- 1.6%
- New position
- Shares
- 193k
- Value
- $139.9m
- Weight
- 1.4%
- New position
- Shares
- 198k
- Value
- $133.8m
- Weight
- 1.4%
- Vistra Corp.Increased
VST
- Shares
- 951k
- Value
- $131.6m
- Weight
- 1.3%
- Reduced
- Shares
- 868k
- Value
- $125.0m
- Weight
- 1.3%
- New position
- Shares
- 933k
- Value
- $97.9m
- Weight
- 1.0%
Values are reported at the period-end price and weights are shares of total disclosed value, not of the investor's whole portfolio. Filed 20 Oct 2026.
Portfolio history
Total reported value of disclosed holdings at each period end. Changes reflect share prices as well as buying and selling.
| Period | Value |
|---|---|
| Q2 2026 | $10.35bn |
| Q3 2026 | $9.82bn |
This investor discloses less often than quarterly; only periods with a published disclosure are shown.
About this investor
Egerton Capital is a London investment manager founded in 1994 by John Armitage. It invests in listed companies around the world.
Approach. Egerton bases its decisions on detailed research into individual companies and aims to own businesses it understands well for the long term.
Disclosure. Form 13F covers only US-listed 13(f) securities, so the firm’s non-US holdings are not shown. Frequency: Quarterly.
What changed
Independent commentary on the latest disclosure. Facts are separated from interpretation.
What the filing shows
No reviewed commentary has been published for this disclosure yet.
Our interpretation
Portfolio activity
Every change between consecutive comparable disclosures, newest first.
Quarter by quarter:What they bought and sold in Q3 2026
27 records
- Increased
3.57m → 4.71m shares
Q3 2026 vs Q2 2026 · Filed 20 Oct 2026 - No longer reported
2.32m → — shares
Absent from the latest disclosure. Not treated as a sale until confirmed.
Q3 2026 vs Q2 2026 · Filed 20 Oct 2026 - Increased
4.87m → 10.71m shares
Q3 2026 vs Q2 2026 · Filed 20 Oct 2026 - Reduced
3.38m → 3.24m shares
Q3 2026 vs Q2 2026 · Filed 20 Oct 2026 - Reduced
1.7m → 1.64m shares
Q3 2026 vs Q2 2026 · Filed 20 Oct 2026 - Reduced
1.09m → 868k shares
Q3 2026 vs Q2 2026 · Filed 20 Oct 2026 - Reduced
1.97m → 1.01m shares
Q3 2026 vs Q2 2026 · Filed 20 Oct 2026 - Reduced
4.38m → 3.63m shares
Q3 2026 vs Q2 2026 · Filed 20 Oct 2026 - Increased
925k → 993k shares
Q3 2026 vs Q2 2026 · Filed 20 Oct 2026 - New position
— → 198k shares
Q3 2026 vs Q2 2026 · Filed 20 Oct 2026
Source records
The record behind every figure on this page. Open a disclosure to see its full source record.
Q3 2026 disclosurePeriod ended 30 Sep 2026 · Filed 20 Oct 2026 · Processed 16 Nov 2026
- Original source document
- SEC Form 13F-HR
- Information table
- Holdings as filed (XML)
- Source type
- SEC Form 13F-HR
- Source reference
- SEC accession 0001581811-26-000009
- Reporting entity
- Egerton Capital (UK) LLP (CIK 0001581811)
- Reporting period end
- 30 Sep 2026 (Q3 2026)
- Filed / published
- 20 Oct 2026
- Processed by Capital Signals
- 16 Nov 2026
- Verification status
- Published
- Reviewer
- Capital Signals data team
- Qualification
- Form 13F covers long positions in US-listed "13(f) securities" only. Shorts, cash, bonds, most non-US shares and private assets are not reported.
Q2 2026 disclosurePeriod ended 30 Jun 2026 · Filed 21 Jul 2026 · Processed 16 Nov 2026
- Original source document
- SEC Form 13F-HR
- Information table
- Holdings as filed (XML)
- Source type
- SEC Form 13F-HR
- Source reference
- SEC accession 0001581811-26-000007
- Reporting entity
- Egerton Capital (UK) LLP (CIK 0001581811)
- Reporting period end
- 30 Jun 2026 (Q2 2026)
- Filed / published
- 21 Jul 2026
- Processed by Capital Signals
- 16 Nov 2026
- Verification status
- Published
- Reviewer
- Capital Signals data team
- Qualification
- Form 13F covers long positions in US-listed "13(f) securities" only. Shorts, cash, bonds, most non-US shares and private assets are not reported.